Ben May Department for Cancer Research

Sort by

Display

Collections

Format

Format

Author/ Creator

Show more

Year

Show more

Collection

Show more

Format

Author/ Creator

Show more

Year

Show more

Collection

Show more
Ben May Department for Cancer Research 84 records found 1 - 25nextSearch took 0.17 seconds. 
1.
Solid tumors are characterized by dysfunctional vasculature that limits perfusion and delivery of nutrients to the tumor microenvironment. Limited perfusion coupled with [...]
02 October 2024 | Ben May Department for Cancer Research | Article |
2.
Immune stimulating agents like Toll-like receptor 7 (TLR7) agonists induce potent antitumor immunity but are limited in their therapeutic window due to off-target immune [...]
07 October 2022 | Ben May Department for Cancer Research; Cancer Biology; Immunology | Article |
3.
Pulmonary neuroendocrine cells (PNECs) are unique airway epithelial cells that blend neuronal and endocrine functions, acting as key sensors in the lung. They respond to [...]
07 August 2024 | Ben May Department for Cancer Research; Medicine | Article |
4.
Somatic structural variations (SVs) in cancer can shuffle DNA content in the genome, relocate regulatory elements, and alter genome organization. Enhancer hijacking occur [...]
25 July 2024 | Ben May Department for Cancer Research; Human Genetics | Article |
5.
The tumor microenvironment is a determinant of cancer progression and therapeutic efficacy, with nutrient availability playing an important role. Although it is establish [...]
24 May 2024 | Ben May Department for Cancer Research[...] | Article |
6.
The proto-oncogene MYC encodes a nuclear transcription factor that has an important role in a variety of cellular processes, such as cell cycle progression, proliferation [...]
23 May 2024 | Ben May Department for Cancer Research; Medicine; Pathology; Radiation and Cellular Oncology; Surgery | Article |
7.
The functional role of progesterone receptor (PR) and its impact on estrogen signaling in breast cancer remain controversial. In primary ER+ (estrogen receptor [...]
24 June 2016 | Ben May Department for Cancer Research | Article |
8.
Metabolism-mediated epigenetic changes represent an adapted mechanism for cellular signaling, in which lysine acetylation and methylation have been the historical focus o [...]
24 February 2021 | Ben May Department for Cancer Research | Article |
9.
Lysine L-lactylation [K(L-la)] is a newly discovered histone mark stimulated under conditions of high glycolysis, such as the Warburg effect. K(L-la) is associated with f [...]
19 January 2022 | Ben May Department for Cancer Research | Article |
10.
Although a clinical breakthrough for cancer treatment, it remains that a minority of patients respond to checkpoint inhibitor (CPI) immunotherapy. The composition of tumo [...]
11 December 2019 | Ben May Department for Cancer Research; Immunology | Article |
11.
Hepatic steatosis is a major etiological factor in hepatocellular carcinoma (HCC), but factors causing lipid accumulation leading to HCC are not understood. We identify B [...]
12 October 2022 | Ben May Department for Cancer Research; Cancer Biology; Molecular Metabolism and Nutrition | Article |
12.
The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and ongoing coronavirus disease 2019 (COVID-19) pandemic underscores the need for new treatment [...]
20 January 2022 | Ben May Department for Cancer Research; Chemistry; Microbiology; Pathology; Surgery | Article |
13.
Fusion genes represent a class of attractive therapeutic targets. Thousands of fusion genes have been identified in patients with cancer, but the functional consequences [...]
09 February 2022 | Ben May Department for Cancer Research; Human Genetics | Article |
14.
Oxysterols are oxidation products of cholesterol. Cholestane-3β, 5α, 6β-triol (abbreviated as triol) is one of the most abundant and active oxysterols. Here, we report [...]
13 June 2013 | Accounting; Ben May Department for Cancer Research; Genetics, Genomics, and Systems Biology | Article |
15.

Cancer and healthy cells have distinct distributions of molecular properties and thus respond differently to drugs. Cancer drugs ideally kill cancer cells while limiti [...]

23 September 2014 | Ben May Department for Cancer Research; Physics | Article |
16.

Cervical cancer is one of the most common cancers in women worldwide, being high-risk group the HPV infected, the leading etiological factor. The raf kinase inhibitory [...]

19 March 2013 | Ben May Department for Cancer Research | Article |
17.

Guanylyl cyclases (GCs) regulate many physiological processes by catalyzing the synthesis of the second messenger cGMP. The GC family consists of seven particulate GCs [...]

29 July 2013 | Ben May Department for Cancer Research | Article |
18.

Background: Recent studies show that mutations in Leucine Rich Repeat Kinase 2 (LRRK2) are the cause of the most common in [...]

01 March 2011 | Ben May Department for Cancer Research | Article |
19.

There is a growing body of evidence that epigenetic alterations are involved in the pathological mechanisms of many chronic disorders linked to fetal programming. Angi [...]

29 August 2014 | Ben May Department for Cancer Research | Article |
20.

Background: Insulin is a vital peptide hormone that is a central regulator of glucose homeostasis, and impairments in insulin signaling cause diabetes mellitus. In pri [...]

07 May 2010 | Ben May Department for Cancer Research | Article |
21.

First-generation interaction maps of Src homology 2 (SH2) domains with receptor tyrosine kinase (RTK) phosphosites have previously been generated using protein microar [...]

04 September 2012 | Ben May Department for Cancer Research; Cancer Biology; Genetics, Genomics, and Systems Biology | Article |
22.

Although triple negative breast cancers (TNBC) are the most aggressive subtype of breast cancer, they currently lack targeted therapies. Because this classification st [...]

11 December 2013 | Ben May Department for Cancer Research; Ecology and Evolution; Molecular Genetics and Cell Biology; Statistics | Article |
23.

Angiogenesis inhibition is an important therapeutic strategy for advanced stage prostate cancer. Previous work from our laboratory showed that sustained stimulation of [...]

15 November 2012 | Ben May Department for Cancer Research | Article |
24.

Recent proteomics studies suggest high abundance and a much wider role for lysine acetylation (K-Ac) in cellular functions. Nevertheless, cross influence between K-Ac [...]

02 December 2011 | Ben May Department for Cancer Research; Pediatrics | Article |
25.

Background: Raf kinase inhibitory protein (RKIP), also known as phoshaptidylethanolamine binding protein (PEBP), has been shown to inhibit Raf and thereby negatively r [...]

05 May 2010 | Ben May Department for Cancer Research; Biochemistry and Molecular Biology; Neurobiology; Pharmacological and Physiological Sciences | Article |

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.